British Prime Minster David Cameron makes Alzheimer's a priority, the need to recruit minorities in the A4 clinical trials, and an online Alzheimer's screening test raises questions about the efficacy of early diagnosis (read more).
Survey finds most people thinking Alzheimer's is a normal part of aging, MIT professors propose new superfund to cure Alzheimer's, and David Cameron doubles down on dementia commitment (read more).
Preparing now for Alzheimer's down the road, the latest on the drug pipeline for Alzheimer's, and privacy concerns with big data and healthcare (read more).
Eli Lilly continues solanezumab studies, 67 Alzheimer's drugs currently being tested, and UC San Diego's efforts to map memory formation (read more).
The need to invest in medical research, the state of anti-aging research, and Pfizer's new research approach (read more).